# A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

> clinical trial · VERIFIED · 2026-07-09

Status: RECRUITING · Sponsor: AstraZeneca · Condition: Advanced Solid Tumors

- Company: AstraZeneca
- Sector: Advanced Solid Tumors
- Primary source: https://clinicaltrials.gov/study/NCT07161414

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.